Larvol Delta - Neoadjuvant-Dupilumab-and-Toripalimab-in-MSS-CRC-Subjects-With-Resectable-Liver-Metastases

Dupixent (dupilumab) - Sanofi, Regeneron

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07277322

Aug 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next